Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Righttothetopon Jan 07, 2021 12:14pm
189 Views
Post# 32242619

RE:Shorts keep piling on despite all time lows

RE:Shorts keep piling on despite all time lowsWrt shorts, some are smarties, some are Twitterites....heck, if I knew squat about this company and read just the last few NRs, I'd be pretty sure things don't look rosy in the short term.

I'm not sure what the hullabaloo is about....did people expect a CxO announcement over the last two weeks?  Or some kind of shipping update when every other damn company on earth is also shut down for 2 weeks?

Truth is, the time for the SP to have gone subterranean was at tax loss....and it held up....the next catalyst to drive this lower would be next Q numbers and all bets are off on where those go....clearly many believe they will be sheet and the uncertainty around leadership won't get resolved.  Equal chances of bad vs. good news happening in the immediate term really, so I can't blame the shorts piling on....

If all of the great work from last year with global reach and partnerships wasn't enough to move any positive needles, then nothing short of cold hard results will....not right but it is what it is....

Games are afoot though, that much is clear.

Lemoyne wrote: That's some pretty dreadfull sentiment there. Short float increased in the last period december 16th to 31st, despite sp dropping to all time lows and remaining there for the whole period, and tax loss selling in full effect.

4.6M reasons people think this is going lower than current levels.

Record short float by the way in absolute numbers. (not in %)

I don't understand how people think this can go alot lower but hey, medipharm has proven them right time and time again.


<< Previous
Bullboard Posts
Next >>